Ales GAVENDA - Ostrava-Lhotka, CZ Pavel VRASPIR - Rymarov, CZ Augusto CANAVESI - Locate Varesino(CO), IT Judith ARONHIME - Rehovot, IL Ettore BIGATTI - Rho, IT Jiri FAUSTMANN - Opava-6, CZ Alexandr JEGOROV - Dobra Voda, CZ Peter W. STEPHENS - Stony Brook NY, US Giovanna LUX - Milano, IT Maurizio PAIOCCHI - Milano, IT
Assignee:
PLUS CHEMICALS SA - Paradiso
International Classification:
C07D 239/72
US Classification:
544293
Abstract:
The preparation of crystalline Erlotinib base form G2 is described. This crystalline form can be converted to an Erlotinib salt, such as Erlotinib HCl, which can be used in the treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC).
West Mercer Elementary School Mercer Island WA 1963-1966, Noddin Elementary School San Jose CA 1966-1967, Howes Elementary School San Jose CA 1967-1967, Mirassou Elementary School San Jose CA 1967-1971